Stem Cell Technology Eases Cancer Treatments

Stem Cell Technology Eases Cancer Treatments

Indianapolis researchers are developing technology which could alleviate negative side effects during stem cell transplants for cancer patients. General BioTechnology’s device pumps bone marrow stem cells through a specially designed tube. The fiber filled tube gradually filters the Dimethyl Sulfoxide preservative from the bone marrow transplant while still maintaining the cell’s efficacy. DMSO is a commonly used preservative which increases the shelf life of cells, but can cause complications with patients when it is injected into their system.

“There has been a demand for this technology as long as frozen bone marrow transplants have been used to treat patients. This project originated through our company’s mission of listening to physicians and specifically developing technologies to meet critical needs,” said Erik J. Woods, Ph.D., president and chief executive officer of General BioTechnology. “Over 30,000 people a year in this country receive this type of procedure, our hope is that our system will help yield better outcomes with fewer complications.”

Related Posts with Thumbnails

Leave a Reply

Contact Us

Tips, Leads, Suggestions, Just Want to Say Hello? Email Dan or Sarah at support (at) stemcellumbilicalcordblood (dot) com